Stem cell therapy promising for rheumatoid arthritis

Stem cell therapy promising for rheumatoid arthritis

The data comes from the first cohort of a phase II trial of its mesenchymal precursor cell (MPC) product, which recruited RA patients who were refractory to treatment with biologic therapies including tumour necrosis factor (TNF) alpha antagonists. A

(Visited 1 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.